CHAMPION PHOENIX
- 10,900 participants
- 5 sites in New Zealand
- 14 countries
Cangrelor versus standard theraphy to achieve optimal management of platelet inhibition
A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention.